Mark A Socinski, MD

Research Reports

Patterns of Biomarker Testing Rates and Appropriate Use of Targeted Therapy in the First-Line, Metastatic Non-Small Cell Lung Cancer Treatment Setting

02/15/2018

Michael A. Savin , MD;

Ravi Salgia , MD, PhD;

Blase Polite , MD;

Corey Shamah , MD;

Mark A. Socinski , MD;

Amanda Barry , MPH;

Kathy Lokay ;

Peter G. Ellis , MD;

Casey Mason ;

Ray Page , DO, PhD, FACOI, FASCO;

Natalie Dickson , MD;

Abstract: Despite clear clinical benefit and guideline recommendations for predictive biomarker testing and subsequent first-line targeted therapy treatment in patients with non–small cell lung cancer (NSCLC), there...

...

02/15/2018

Journal of Clinical Pathways

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

March 17 ⁠–⁠ March 19

March 27 ⁠–⁠ March 30

See Full Calendar

Mark A Socinski, MD

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products